Anna Beaumont, from Dunfermline, has fulfilled a lifelong ambition to become a nurse, joining the NHS Greater Glasgow and Clyde Royal Hospital for Children's Schiehallion unit. The 28-year-old mother of three was inspired to pursue nursing at the age of six, during her own hospital treatment, when she wrote down her dream with a play specialist.
Now working with children and young people battling cancer and blood disorders, Beaumont is one of over 500 newly registered nurses who have joined NHSGGC this autumn. She expressed her deep satisfaction, stating, “This is the only place I’ve ever wanted to work. This is literally my life’s ambition getting fulfilled.”
“"I wrote a wee biography with my play specialist when I was a wee girl and said that I was going to be a nurse. And here we are. I started in Ward 2 in September, and it’s been everything that I hoped it would be. The staff are lovely and the kids are great. This is me. I’m set."
Beaumont's motivation is deeply personal, stemming from her own childhood experience with kidney disease and her role as a mother of twins. She aims to make a significant difference in the lives of her young patients, drawing on her understanding of their experiences. "My whole purpose is to come in and be kind and good at my job," she explained.
Professor Angela Wallace, Executive Director of Nursing and Midwifery at NHSGGC, welcomed the new cohort of nurses. "Stories like Anna’s reflect the passion and motivation throughout our teams," she said. "We’ve welcomed more than 500 new nurses this year and they all have their own stories to tell. It makes me incredibly proud to see the breadth of backgrounds within our teams but the one consistent motivation throughout is the desire to provide the best care they possibly can for others."
The new nurses will support teams across various services in hospitals and the community within the six Health and Social Care Partnerships. Ward 2A/2B, where Beaumont is based, specialises in caring for children and young people with blood-borne diseases and cancers.
